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Summary
Objective: To identify genes which may be involved in the development of anterior cruciate ligament (ACL) laxity and rupture in a naturally
occurring canine osteoarthritis (OA) model.
Design: Three groups of dog were studied: (1) dogs with ACL rupture; (2) dogs with intact ACLs from a breed predisposed to ACL rupture;
(3) dogs with intact ACLs from a breed at very low risk of rupture. The transcriptomes of the ACLs from each group were compared using
a whole genome microarray and quantitative reverse transcriptase polymerase chain reaction. Differential gene expression in ruptured canine
ACLs was compared with that published in the literature for ruptured human ACLs.
Results: No signiﬁcant differences were identiﬁed between the gene expression proﬁles of normal ACLs of a breed predisposed to ACL rup-
ture when compared to a breed relatively resistant to ACL rupture. A general pattern of increased protease and extracellular structural matrix
gene expression was identiﬁed in the ruptured ACLs when compared to intact ACLs. The gene expression proﬁles of ruptured canine ACLs
demonstrate similar patterns to those previously reported for ruptured human ACLs.
Conclusions: A transcriptomic basis to breed speciﬁc risk for the development of canine ACL rupture was not identiﬁed. Although changes in
matrix associated gene expression in the ruptured ACL are similar between humans and dogs, the molecular events which may predispose to
ACL laxity and rupture were not deﬁned.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Joint laxity is hypothesised to be an important contributor to
the pathogenesis of human knee OA, with laxity in the
valgusevarus1 and anterioreposterior1,2 planes increasing
with the severity of OA. The anterior cruciate ligament
(ACL) is the primary stabiliser of the knee joint, and rupture
of this ligament results in joint instability and the develop-
ment of osteoarthritis (OA)3e5. ACL rupture is identiﬁed
more commonly in patients with knee OA6, although this
is not necessarily a sequel to a previous traumatic event6.
Pathological changes to the ACL resulting in knee laxity
may predispose patients to knee OA. This hypothesis is
supported by spontaneous animal models of OA which
highlight the association of ligament laxity, speciﬁcally of
the ACL, and the development of OA7. A similar spontane-
ous condition is recognised in dogs where disease of the
canine anterior (cranial) cruciate ligament results in a pro-
gressive pathological failure of the ligament (rupture), the*Address correspondence and reprint requests to: Dylan Neil
Clements, B.Sc., B.V.Sc., Musculoskeletal Research Group,
Faculty of Veterinary Science, University of Liverpool, Liverpool,
L69 3BX, UK. Tel: 44-7803203551; Fax: 44-1517944219; E-mail:
dylan.clements@liverpool.ac.uk
Received 21 December 2006; revision accepted 6 June 2007.
195development of joint instability and secondary OA8. Exper-
imental transection of the ACL in normal dogs results in
the spontaneous and progressive development of stiﬂe
OA9, and highlights the importance of joint stability, and par-
ticularly ACL integrity, to prevent OA.
Epidemiological studies reveal that dogs demonstrate
a breed-associated risk to ACL rupture10,11, with ‘‘at-risk’’
breeds such as the Labrador Retriever (LR) demonstrating
much higher levels of risk than ‘‘protected’’ breeds, such as
the Greyhound (GH). Dogs from breeds predisposed to
ACL rupture have reduced ligament stiffness and reduce
load to ultimate failure when compared to dogs from breeds
format low risk of ACL rupture12e14. This implies that the ge-
netic susceptibility to the development of ACL rupture man-
ifests itself through changes in the mechanical properties of
the ACL. Increased levels of pro-matrix metalloproteinase-2
(pro-MMP-2) have been identiﬁed in normal ACLs of dogs
with a high-risk of ACL rupture (LR) compared to dogs
with a low risk of ACL rupture (GH)14. Similar changes in
gross ACL biomechanical properties (increasing laxity)
have been related to molecular differences (increased
MMP-2 and pro-MMP-2 protein) in the ACL in an animal
model of spontaneous knee OA7, further supporting the
link between the development of knee OA, knee laxity
and molecular changes at a cellular level.
196 D. N. Clements et al.: Gene expression of canine anterior cruciate ligamentsThe histological appearance of the normal canine ACL
is very similar to that of the normal human ACL15, although
the identiﬁcation of other features such as chondroid
metaplasia cells is more common in the normal canine
ACL16. Following human ACL rupture, four histological
phases are recognised, namely, inﬂammation (0e3
weeks), epiligamentous regenerations (3e8 weeks), prolif-
eration (8e32 weeks), and remodelling (1e2 years)17.
Although gross histological features of ACL rupture are
also similar in both humans and dogs, the ruptured canine
ACL demonstrates more severe matrix degeneration,
chondroid metaplasia and inﬂammation on histological
evaluation than ruptured human ACL16. Inﬂammation is
a component of naturally occurring ACL rupture, as recog-
nised in histological sections of the synovial membrane18
and ligament16, although synovial ﬂuid cytology proﬁle in
the vast majority of cases is non-inﬂammatory19.
Gene expression within the normal and pathological ACL
has not been extensively studied in either humans or ca-
nines. In man the ruptured ACL expresses higher quantities
of messenger RNA (mRNA) coding for Type I collagen
(COL1), Type III collagen (COL3), biglycan (BGN) and tis-
sue inhibitor of metalloproteinase-1 (TIMP-1), than the nor-
mal (non-ruptured) ACL20. In dog, the mRNA expression of
matrix metalloproteinase-2 (MMP-2) and matrix metallopro-
teinase-9 (MMP-9), tartrate-resistant acid phosphatase
(TRAP) and cathepsin S (CTSS) have been reported to
be increased in the ruptured ACL when compared to normal
ACL21, although studies of proteins present suggest that
pro-MMP-2 is increased in the ruptured canine ACL, but
there are no changes in active MMP-2, MMP-9, TIMP-1 or
TIMP-222.
Differences between the transcriptome of ruptured and
normal tissue can be identiﬁed by gene expression proﬁling.
Canine speciﬁc microarray (MA) platforms are now avail-
able to perform genome wide expression proﬁling of canine
cells from dissected tissues23. MA analysis has allowed the
identiﬁcation of differential gene expression pathways in
connective tissues, such as cartilage and tendon, which fur-
ther improves our understanding of the molecular pathways
involved in OA24,25 and tendon repair26.
We hypothesised that altered gene expression proﬁles
would be identiﬁed when comparing the transcriptome of
the normal ACL from dogs of breeds predisposed to ACL
rupture (LR), and those at low risk from ACL rupture
(GH). Secondly, we hypothesised that in breeds at risk of
ACL rupture differential expression of genes would be iden-
tiﬁed between the transcriptomes of normal ACL and the
ruptured ACL. Finally, we hypothesised that genes which
have been previously reported as being differentially ex-
pressed in the ruptured human ACL would demonstrate
similar patterns of expression to those we identiﬁed in rup-
tured canine ACL.MethodsRNA EXTRACTIONNormal canine ACLs were harvested by sharp dissection
and from the knees (stiﬂes) of dogs (seven LRs [mean age
5.4 years {standard deviation (SD)þ/ 3.3 years, range
1e10 years}, three male neutered, two female neutered,
one entire male and one entire female mean weight
28.7 kg {SDþ/ 2.4 kg, range 25e32 kg}], ﬁve GH [mean
age 3.8 years {SDþ/ 4.1 years, range 1.5e10 years},
three entire female, two entire male, mean weight 33.0 kg
{SDþ/ 3.8 kg, range 30e38 kg}]) without any evidenceof knee pathology, and which were euthanatized for rea-
sons unrelated to orthopaedic disease. The central third of
the ligament was preserved. Ruptured canine ACLs were ob-
tained from ﬁve LRs (mean age 7.7 years [SDþ/ 1.6
years, range 5.5e10 years], three neutered male, one neu-
tered female, one male, mean weight 33.4 kg [SD þ/3.0 kg,
range 30e37 kg]) during routine surgical treatment for the
ACL rupture (medial parapatellar arthrotomy), and stored
in RNAlater as recommended by the manufacturer
(Qiagen Ltd., Crawley, UK). All dogs with ACL rupture
had radiographic evidence of stiﬂe OA (osteophytosis).RNA EXTRACTION AND QUALITY ASSESSMENTTissue samples were removed from RNAlater and total
RNA was extracted using phenol/guanidine HCl reagents
(Trizol, Invitrogen Ltd., Dorset, UK) and isolated as previ-
ously described including the use of an on-column DNA di-
gestion step27,28, RNA integrity was analysed by evaluating
the capillary electrophoresis trace (Agilent 2100 Bioana-
lyser, Agilent Technologies, California, USA) of the sample
using the RNA integrity number (RIN) algorithm29, Degrada-
tion factor (DF)30 and ribosomal peak ratio. The samples
determined to have no, or minimal, loss of integrity were
deemed suitable for use in experiments in accordance
with a previously developed quality algorithm28.RNA AMPLIFICATIONmRNA was ampliﬁed for each sample, starting with
200 ng total RNA using a commercially available kit
(Ambion T7 MEGAscript high yield transcription kit,
Ambion (Europe) Ltd, Huntingdon, Cambridge, UK) as pre-
viously described31. A second round of mRNA ampliﬁcation
was performed using MessageAmp ampliﬁed RNA
(aRNA) Ampliﬁcation kit (Ambion (Europe) Ltd), as de-
scribed by the manufacturer. The aRNA was quantiﬁed us-
ing a spectrophotometer.aRNA LABELLINGTwo micrograms of aRNA were labelled with Cyanine-
3dCTP (Cy3) or Cyanine-5dCTP (Cy5), using a ﬂuorescent
dye labelling kit (Agilent Technologies UK Ltd., South
Queensferry, UK) as described by the manufacturer. Fluo-
rescence incorporation was determined using a spectropho-
tometer, ensuring that > 750 ng cRNA was labelled, and
that the label incorporation was >8 pmol per mg RNA. Sam-
ples were stored at 80C until use.MA HYBRIDISATION, SLIDE READING, DATA NORMALISATION
AND STATISTICSSamples hybridised to a canine speciﬁc, custom de-
signed, whole genome 44219 spot 60mer oligonucleotide
MA chip32 and read using an Agilent DNA MA Slide Reader,
and ﬂuorescence data extracted by employing the Agilent
Feature Extraction 8.5 software (Agilent Technologies UK
Ltd). For full details see Supplementary material. Data
were imported into Genedata Expressionist Analyst (Gene-
data AG, Basel, Switzerland), and the Cy3 and Cy5 ﬂuores-
cence intensities normalised using locally weighted linear
regression (LOWESS)33. Expression data were then ex-
ported into Excel 2003 and comparison between groups
was achieved using paired student’s t tests. Comparisons
of the number of genes up- or down-regulated in both the
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the normal LR ACL were made using Chi squared analysis
(Minitab v14.1, Minitab Ltd, Coventry, UK). Correction for
multiple hypothesis testing was performed using the Benja-
mini and Hochberg false discovery rate (FDR)34. Correct P
values were calculated by dividing the true P value by the
individual correction factor and multiplying by 0.05.QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE
CHAIN REACTION (RT-QPCR)The original (un-ampliﬁed) mRNA samples used for the
MA experiments, and further suitable high grade RNA sam-
ple collections from further patients with stiﬂe OA and ACL
rupture (totals, n¼ 21 ruptured ACL [mean age 6.3 years
{SDþ/ 2.7 years, range 2e12 years}, seven female
neutered, eight male neutered, three entire female, three
entire male, mean weight 32.7 kg {SDþ/ 6.9 kg, range
24e55 kg}], n¼ 13 normal LR ACLs [mean age 4.9 years
{SDþ/ 3.0 years, range 1e10 years}, two female neutered,
two male neutered, ﬁve entire male, four entire female, mean
weight 28.8 kg {SDþ/ 3.5 kg, range 21e34 kg}]) and n¼ 7
normal GH ACLs [mean age 3.7 years {SDþ/ 3.0 years,
range 1.5e10 years}, three entire female, four entire male,
mean weight 31.7 kg {SDþ/ 2.0 kg, range 30e35 kg}])
were obtained and used in RT-qPCR experiments. Reverse
transcription was performed as previously described35. The
age andweights were compared by student’s t tests, and sex
and neuter status were compared by Fisher’s exact tests.
Signiﬁcance was set at P< 0.05.ASSAY DESIGNGenes were selected for assaying on the basis of their
perceived relevance to the ACL extracellular matrix (from lit-
erature review), and the results of the MA screen. Assays
were designed for quantiﬁcation of expression of 23 genes
of interest and ﬁve reference genes, as previously de-
scribed35. The primer and probe sequences for each assay
have been previously published35 or are listed in Table I.
The assays were used to quantify; three collagen genes
(Type I collagen, alpha two chain (COL1A2), Type III colla-
gen alpha 1 chain (COL3A1), Type V collagen alpha 1 chain
(COL5A1)), seven extracellular matrix genes (aggrecan
(AGC1), BGN, chondroitin sulphate proteoglycan 2 (Versi-
can/CSPG2), decorin (DCN), lumican (LUM), tenascin C
(TNC), vimentin (VIM)), proteases and their inhibitors (a dis-
integrin and metalloproteinase with thrombospondin-like
motif-4 (ADAMTS-4), -5 (ADAMTS-5), cathepsin B (CTSB)
and D (CTSD), MMP-2, MMP-9, and MMP-13, caspase-8
(CASP-8), tissue inhibitors of metalloproteinase-1 (TIMP-1)
and-2 (TIMP-2)), a growth factor (insulin like growthTable
Primer and probe sequences fo
Gene Forward
ADAMTS-4 GACCAGTGCAAACTCACCTG
B2M CCTTGCTCCTCATCCTCCT
CASP-8 GAGCTTCAGATACCAGGCAGA
COX2 AAATTGCTGGCAGGGTTG
IGF-1 GGGGGTTCTACTTCAACAAGC
MMP-2 ACCTGCAAGGCAGTGGTC
MMP-9 CACGCATGACATCTTCCAGT
NOS2A GGCTCAAATCACAACGGAATfactor-1 (IGF-1)), prostaglandin-G, -H synthetase-2
(PTGS-2), inducible nitric oxide synthetase 2A (NOS2A),
genomic DNA (GEN), and ﬁve reference genes (selected
using a previously published reference gene stability algo-
rithm36; beta 2-microglobulin (B2M), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), TATA box binding
protein (TBP), ribosomal protein L13a (RPL13A) and succi-
nate dehydrogenase complex, subunit A (SDHA)). Locked
nucleic acid probes with a 50 reporter dye FAM (6-carboxy
ﬂuorescein) and 30 quencher dye TAMRA (6-carboxytetra-
methyl-rhodamine) were synthesised by Roche Diagnostics
Ltd. (Lewes, West Sussex, UK).
The RT-qPCR assays were all performed in triplicate us-
ing a TaqMan ABI PRISM 7900 SDS (Applied Biosys-
tems, California, USA) in 10 ml volumes in 384-well plate
format, as previously described35, and are further described
in Supplementary material.RT-qPCR DATA ANALYSISGeometric means36 were calculated for the combined
three reference genes (B2M, SDHA, TBP), and used to
calculate the deltaedelta CT values and the relative amount
of each target gene37. Two reference genes (GAPDH and
RPL13A) were not included in the calculations, because
they had near-differential expression between the normal
and ruptured ligament samples, and the normal LR and
GH ACL samples respectively, even when included as
a part of the normalisation calculation. Quantitative PCR
data for each group were compared with the calculations
of means, SDs, fold changes from normal and paired two-
tailed t tests (body weight and age) performed in a spread-
sheet program (Microsoft Excel 2003). Signiﬁcance was
established at P< 0.05, and data were checked for errors
due to multiple hypothesis testing using the Benjamini and
Hochberg false discovery rate (FDR)34.CLUSTER ANALYSISThe normalised MA data for 63 genes differentially ex-
pressed between ruptured (LR) ACL when compared to
normal (LR) ACL and with complete annotation were loaded
into a gene clustering software (Cluster, Eisen Labs, http://
rana.lbl.gov/EisenSoftware.htm). Data were log trans-
formed and genes centered to the mean. Hierarchical
clustering of differentially expressed genes was then
performed for arrays and genes using Spearman’s Rank
Correlation and complete linkage link clustering. Clustering
of genes and arrays were visualised with publicly available
software (TreeView, Eisen Labs, http://rana.lbl.gov/
EisenSoftware.htm).I
r quantitative PCR assays
Reverse Probe
CAGGGAGTCCCATCTACCAC GGCCCTGG
TGGGTGTCGTGAGTACACTTG CAGCATCC
TGAAATCTGAAAAAGCATGACC CTCTGCCT
TCGAAGCTTTTGCTACTTGTTG GGTGGCAG
TCATCCACGATGCCTGTCT CTCCAGCA
TCCAAATTTCACGCTTTTCA AGCTGGAG
CGAGAATTCACACGCCAGTA CTTCTGCC
AGAGCTCGACCAGGAGAGTG CCAGCCGC
198 D. N. Clements et al.: Gene expression of canine anterior cruciate ligamentsResultsCOMPARISON OF PATIENT SIGNALMENTA signiﬁcant difference (P¼ 0.025) was noted in the pa-
tient weight of tissues used in the MA experiment to com-
pare the ruptured ACL LRs and the normal ACL LRs. A
second signiﬁcant difference (P¼ 0.024) was noted in neu-
ter status of the patients used in the RT-qPCR experiment
to compare the ruptured ACL LRs (more likely to be neu-
tered) and the normal ACL LRs. No other differences in
age, weight sex or neuter status were determined.MAIn the normal GH ACL, compared to the normal LR ACL,
925 transcripts were up-regulated (P< 0.05). Conversely
1050 transcripts were down-regulated in the normal GH
ACL, compared to the normal LR ACL. Of the 925 tran-
scripts up-regulated in the normal GH ACL, 455 were also
signiﬁcantly up-regulated in the ruptured LR ACL whenTable I
Identification of genes up- or down-regulated (three fold or more) when c
analysi
Gene ID Name Ref seq numbe
NAP1L1 Nucleosome assembly
protein 1-like 1
XM_847704
COL3A1 Collagen 3, alpha 1 XM_858055
RGS10 Regulator of G-protein signalling 10 XM_535032
MARCKS Myristoylated alanine-rich
protein kinase C substrate
XM_850164
CDH11 Cadherin 11, type 2, OB-cadherin XM_859908
SPARC Osteonectin XM_8499
STMN1 Stathmin 1 XM_861033
ZSWIM2 Zinc ﬁnger, SWIM domain
containing 2
XM_535994
TMSB10 Thymosin beta-10 XM_849812
LGALS1 Lectin, galactose
binding, soluble 1
XM_549042
CENPH Centromere protein H XM_847537
ALDH1L2 Aldehyde dehydrogenase 1 family,
member L2
XM_531763
ANKRD10 Ankyrin repeat
domain 10
XM_843234
RET RET tyrosine
kinase/camp protein
kinase A subunit RI
XM_543915
CAV1 Caveolin 1 NM_001003296
TUBB Beta-tublin XM_532060
TUBA Alpha-tubulin XM_857454
ATP11B Atpase, class I, type 11B XM_535816
WDR1 WD repeat
domain 1
XM_848702
SNX6 Sorting nexin 6 XM_547770
ACTB Beta actin XM_845524
IGFBP7 Insulin-like growth
factor binding protein 7
XM_856005
ADK Adenosine kinase,
transcript variant 3
XM_858911
CCNB1 Cyclin B1 XM_544149
SSR2 Signal sequence
receptor, beta
NM_001003269
CIDEB Cell death-inducing DNA fragmentation
factor, alpha
subunit-like effector B
XM_848904
FAT4 FAT tumour
suppressor homolog 4
XM_843601
ACTR3 Actin-related protein 3 XM_848216compared to the normal LR ACL, and 450 of the 1070 tran-
scripts were down-regulated in both the normal GH ACL
and LR ACL when compared to the normal LR ACL. The
number of transcripts whose expression was increased or
decreased in both normal GH ACL and ruptured LR ACL
was signiﬁcantly greater (P< 0.001) than by chance alone.
The FDR determined that none of the transcripts were sig-
niﬁcantly up- or down-regulated when corrected for multiple
hypothesis testing.
Four thousand and thirty-eight transcripts were up-regu-
lated in ruptured LR ACL when compared to normal LR
ACL. Five thousand and nineteen transcripts were down-
regulated in ruptured LR ACL when compared to the normal
LR ACL. The FDR determined that 99 transcripts were sig-
niﬁcantly up-regulated and 17 transcripts were signiﬁcantly
down-regulated when corrected for multiple hypothesis test-
ing. Eighty-seven transcripts (of which 24 transcripts were
repeats) had a deﬁned annotation and 29 transcripts had
no deﬁned annotation. The annotated transcripts whose ex-
pression was changed by three fold are listed in Table II.I
ompared between ruptured ACL and normal ACL in LRs in the MA
s
r Function Fold change Corrected P value
Nucleic acid processing 19.0þ/ 7.4 0.0373
Structure 9.5þ/ 4.0 0.0328
Signalling 8.2þ/ 2.5 0.0220
Structure 7.8þ/ 2.2 0.0189
Structure 6.9þ/ 2.4 0.0476
Signalling 6.3þ/ 2.1 0.0387
Structure 6.2þ/ 1.7 0.0194
Unknown 5.9þ/ 1.9 0.0328
Structure 5.7þ/ 1.9 0.0388
Signalling 5.4þ/ 1.3 0.0195
Nucleic acid processing 5.4þ/ 1.8 0.0480
Metabolism 5.3þ/ 1.6 0.0345
Nucleic acid processing 5.2þ/ 1.3 0.0207
Signalling 4.9þ/ 1.7 0.0478
Structure 4.8þ/ 0.9 0.0137
Structure 4.8þ/ 1.4 0.0255
Structure 4.7þ/ 1.0 0.0195
Transport 4.7þ/ 1.5 0.0381
Structure 4.4þ/ 1.3 0.0263
Signalling 4.4 þ/ 0.9 0.0158
Structure 3.8þ/ 0.8 0.0188
Signalling 3.7þ/ 0.8 0.0196
Signalling 3.6þ/ 1.1 0.0472
Structure 3.6þ/ 0.4 0.0009
Transport 3.5þ/ 0.9 0.0342
Signalling 3.2þ/ 0.9 0.0477
Signalling 3.0þ/ 0.7 0.0341
Structure 0.3 þ/ 0.1 0.0379
199Osteoarthritis and Cartilage Vol. 16, No. 2RT-qPCRThe results of the RT-qPCR are presented in Table III.
Two genes (COL5A1 and RPL13A) were determined to
be up-regulated (P< 0.05) in the normal LR ACL when
compared to the normal GH ACL. The FDR determined
that neither gene was signiﬁcantly up-regulated.
Sixteen genes were signiﬁcantly up-regulated (n¼ 14) or
down-regulated (n¼ 2) in the ruptured LR ACL, when com-
pared to the normal LR ACL. The FDR determined that 14
of these genes were signiﬁcantly up-regulated, after cor-
recting for multiple hypothesis testing (AGC, CASP-8,
COL1A2, COL3A1, COL5A1, CTSB, CTSD, IGF-1, LUM,
MMP-2, MMP-9, COX2, TIMP-1, and TNC) and two were
signiﬁcantly down-regulated (DCN, TIMP-2).
When the RT-qPCR results for the sample subsets used
for MA analysis were examined separately, 12 genes were
signiﬁcantly up-regulated in the ruptured LR ACL when
compared to the normal LR ACL, of which eight genes
were still signiﬁcantly up-regulated after FDR correction
(AGC, CASP-8, COL1A2, COL3A1, CTSB, MMP9, TIMP-1,
and TNC). One gene was determined as being up-regulated
in the normal LR ACL when compared to the normal GH
ACL (IGF-1), although this was not signiﬁcant when cor-
rected for multiple hypothesis testing.
When FDR correction was applied to MA data, but only
to the 24 candidate genes evaluated by RT-qPCR, then 11
genes were determined to be signiﬁcantly up-regulated
(CASP-8, COL1A2, COL3A1, COL5A1, CTSB, GAPDH,
IGF-1, LUM, MMP-13, TIMP-1, and TNC). Nine of these
genes (with the exceptions being MMP-13 and GAPDH)
were conﬁrmed to be signiﬁcantly up-regulated in the
larger cohort of samples evaluated the RT-qPCR. When
FDR correction was applied to the complete MA data set
(41623 genes), only two genes evaluated by RT-qPCRTable I
Gene expression folds change and significance (uncorrected P values)
(GH) as determined by MA, RT-PCR of MA samples (MA RT-PCR), and R
(to 24 genes) ar
MA
Ratio LD
vs LN
P value Ratio GH
vs LN
P value Ratio LD
vs LN
P value
ADAMTS-4 1.0 0.982 1.1 0.408 0.9 0.881
ADAMTS-5 0.8 0.605 1.6 0.286 0.3 0.248
AGC 3.9 0.043 0.5 0.126 13.9 0.007
BGN 1.7 0.086 0.9 0.795 0.9 0.916
CASP-8 1.8 0.000 0.9 0.479 2.1 0.003
COL1A2 12.8 0.001 0.7 0.306 14.3 0.004
COL3A1 9.5 0.000 0.6 0.086 18.7 0.004
COL5A1 3.9 0.004 0.9 0.727 6.4 0.025
CSPG2 0.8 0.078 0.8 0.818 1.0 0.893
CTSB 6.0 0.012 0.7 0.293 5.6 0.010
CTSD 1.0 0.475 1.0 0.756 1.9 0.201
DCN 0.7 0.100 0.9 0.742 0.5 0.053
GAPDH 2.6 0.011 0.6 0.124 1.4 0.327
IGF-1 2.2 0.001 1.3 0.029 3.4 0.086
LUM 3.5 0.012 0.4 0.035 3.5 0.025
MMP-13 2.2 0.023 1.2 0.420 13.5 0.051
MMP-2 36.1 0.042 1.5 0.345 34.1 0.032
MMP-9 1.5 0.068 1.1 0.758 336.4 0.013
NOS2 0.7 0.515 1.8 0.450 0.0 0.324
PTGS-2 1.0 0.990 1.3 0.228 4.9 0.033
TIMP-1 6.2 0.020 0.9 0.791 3.0 0.002
TIMP-2 1.0 0.889 0.6 0.143 0.5 0.107
TNC 2.4 0.008 1.1 0.136 4.6 0.008
VIM 1.1 0.607 0.7 0.125 1.1 0.601were differentially expressed (CASP-8 and COL3A1).
Both these genes were also differentially expressed in
the larger cohort of samples evaluated by RT-qPCR.
Overall, for genes signiﬁcantly up- or down-regulated by
either MA (n¼ 2), RT-qPCR of a larger cohort of samples
(n¼ 7) or both techniques (n¼ 9), the direction fold
change in expression agreed for all except one gene
(TIMP-2, down-regulated in RT-qPCR samples). A graph-
ical representation of the fold changes in expression of
genes up-regulated in ruptured LR ACL, as determined
by MA, is illustrated in Fig. 1.CLUSTER ANALYSISThe corresponding hierarchical cluster analysis plot is
presented in Fig. 2. Clustering of the arrays illustrates clear
separation of the ruptured and normal samples, which is un-
surprising as the list of genes clustered was ﬁltered on sig-
niﬁcance of differential expression between normal and
ruptured. Samples of three of the four dogs from a breed
at low risk of ACL rupture (GH) demonstrated patterns of
gene expression which clustered together, and which
were more closely related to ruptured ACL than those
from dogs at high-risk of ACL rupture. Clustering of the
genes demonstrated alignment of genes known to have
similar function, such as alpha-tubulin (TUBA), beta-tubulin
(TUBB), alpha-actin (ACTA) and beta-actin (ACTB) within
closely related branches, supports both the method of anal-
ysis and the validity of the data.Discussion
Differential gene expression was identiﬁed in ruptured
ACL when compared to normal LR ACL using bothII
in ruptured LR ACL (D), normal LR ACL (N) and normal GH ACL
T-qPCR of all samples (signiﬁcant results, surviving FDR correction
e in bold)
MA RT ALL RT
Ratio GH vs LN P value Ratio LD
vs LN
P value Ratio GH
vs LN
P value
51.7 0.365 2.7 0.084 3.4 0.558
4.4 0.278 0.6 0.217 1.9 0.427
0.9 0.759 14.3 0.000 1.1 0.814
1.3 0.702 1.6 0.133 1.2 0.652
0.9 0.630 1.5 0.028 0.9 0.574
0.9 0.849 11.5 0.000 1.0 0.905
0.9 0.839 16.0 0.000 1.1 0.854
0.5 0.117 9.9 0.003 0.5 0.019
0.7 0.498 1.0 0.910 0.7 0.319
0.9 0.499 4.7 0.000 1.0 0.920
2.1 0.115 2.9 0.001 1.3 0.389
0.7 0.175 0.5 0.000 0.8 0.462
1.1 0.606 1.6 0.043 1.2 0.204
4.3 0.042 3.8 0.003 2.0 0.071
0.7 0.226 2.4 0.002 0.8 0.238
3.3 0.449 21.9 0.038 2.7 0.402
1.2 0.612 24.5 0.000 1.1 0.793
1.2 0.826 491.9 0.018 1.5 0.526
20.1 0.395 0.2 0.225 9.6 0.445
1.4 0.622 6.0 0.028 0.7 0.474
1.5 0.492 5.3 0.001 1.0 0.952
0.6 0.180 0.6 0.006 0.7 0.132
0.9 0.897 4.7 0.000 0.9 0.650
0.9 0.567 1.1 0.418 1.1 0.593
Fig. 1. Fold change in gene expression patterns of candidate genes
in ruptured ACL when compared to normal ACL from high-risk dogs
(LR) as determined by MA, RT-qPCR of MA samples (MA RT-
qPCR), and RT-qPCR of all samples. The candidate genes
selected for comparison are those differentially expressed by MA
evaluation.
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overall pattern of gene expression reported in the ruptured
ACL suggests that both catabolism (MMP and CTS produc-
tion) and repair (collagen and extracellular matrix produc-
tion)38 are increased in the ruptured canine ACL when
compared to the normal ACL. The changes in gene expres-
sion are consistent with both histological features of colla-
gen disruption and epiligamentous repair39 and molecular
changes21 reported in the ruptured canine ACL. Complete
ACL rupture was diagnosed in all joints from which dis-
eased tissues were obtained. To date, the results of primary
repair of ruptured ACLs have been poor both in man40 and
animal models38. Thus the anabolic response of the rup-
tured ACL, which has lost its ability to resist mechanical
load, would appear to be futile.
A transcriptomic basis for breed risk to ACL rupture was
not identiﬁed. Over 40% of genes up- or down-regulated in
the GH ACLs (before correction for multiple hypothesis test-
ing) showed a similar differential expression as observed in
the transcriptome of ruptured LR ACLs, suggesting that ex-
pression proﬁles reported for normal GH ACLs were more
akin to those identiﬁed in the ruptured LR ACLs. Further-
more, hierarchical cluster analysis of the most differentially
expressed genes in ruptured ACL demonstrated clustering
and separation of the expression proﬁles of three of the
four low risk (GH) normal ACL samples from the high-risk
(LR) normal ACL samples. Thus, a transcriptomic basis to
the breed speciﬁc risk may exist, but our methods were
not sensitive enough to characterise it. Alternatively the
small sample size evaluated by MA may have dictated
that individuals in the high-risk group were simply not at
risk of ACL rupture, although the breed itself is, because
ACL rupture does not affect all individuals in the breed.
Conversely, one may interpret the results to indicate that
a transcriptomic risk to the development of ACL rupture truly
does not exist, despite differences in relative risk of ACL
rupture between dog breeds10,11, and biomechanical12,14
and biochemical14,41 differences in the intact ACL between
dog breeds protected or at risk of ACL rupture. Clearly,
there are advantages in using laboratory animal models of
disease, which demonstrate a consistent phenotype, thus
providing more homogeneous information as to the molec-
ular basis to the disease. However, such models may notalways reﬂect polygenetic nature to a disease, or the asso-
ciated environmental inﬂuences, which the canine popula-
tion shares with its human counterparts.
Although no pathways were consistently represented in
the differentially expressed genes as determined by MA,
a number of interesting and functionally related rupture as-
sociated genes were up-regulated. ACTA, ACTB, TUBB
and TUBA are all genes encoding intracellular structural
molecules, whose up-regulation suggests and increase in
cytoplasmic activity in ruptured LR ACLs. SPARC (osteo-
nectin), an extracellular matrix protein which is involved in
ligament development, remodelling and repair42, was also
increased in ruptured LR ACLs, suggesting that the gene
may have a key role in the response to ACL rupture. The
majority of the genes identiﬁed as being differentially ex-
pressed in ruptured ACL have no previous known associa-
tion with OA or ligament pathology, which makes their
precise role in the ruptured ACL difﬁcult to deﬁne.
The normal resorption of ACL matrix collagen has been
hypothesised to occur by ﬁbroblast phagocytosis and intra-
cellular digestion with lysosomal CTSs, whereas inﬂamma-
tory remodelling of collagen is thought to be mediated by
MMPs 43. Our results suggest that both processes are ac-
tive, as there were increases in the expression of both
CTSB and CTSD and MMP-2 and MMP-9 expressions
were identiﬁed in the ruptured ACL, although the relative im-
portance of expression changes in each of the molecules
requires further study. Ligament CTSB expression increases
with mechanical stress44, and the experimental induction
of immune-mediated synovitis increases CTSD in synovial
ﬂuid, with concomitant reduction in the mechanical proper-
ties of the ACL45. At the protein level, pro-MMP-2 is raised
in ruptured ACLs in dogs22. Increased TIMP-1 expression
was identiﬁed in ruptured ACLs, which is consistent with
evaluation of gene expression in ruptured ACLs20, although
this increase does not reﬂect enzyme activity in ruptured
canine ACLs22. The reduced expression of TIMP-2 in ACL
rupture is interesting, because this is contrary to the change
one may expect on the basis of its biological activity yet is
consistent with similar reductions in the expression of this
gene reported in osteoarthritic articular cartilage35,46 and
reductions in the level of protein of this gene reported in
the synovial ﬂuid of dogs with ACL rupture47.
Up-regulation of extracellular matrix gene expression
(COL1A2, COL3A1, COL5A1, AGR, LUM and TNC) sug-
gests increased extracellular matrix production as part of
an attempted reparative process. This concurs with reports
documenting an increased expression of COL1 and COL3
in the ruptured human ACL when compared to normal
(non-ruptured) ACLs20 although we did not record an in-
creased expression of BGN in ruptured canine ACLs, as
has been reported for ruptured human ACLs20. Reduced
expression of a number of these genes (COL1, COL3,
DCN and LUM) is reported in the ACL of rabbits during
pregnancy, and is associated with a concurrent increase
in ACL laxity48. We did not record a detectable difference
in the expression of these genes in the normal ACL of
two breeds known to demonstrate different laxity measure-
ment14. Interestingly a similar pattern of gene expression
changes (increased COL1A2, COL3A1, COL5A1, LUM
and TNC gene expression) is also reported in end-stage ca-
nine hip OA cartilage35, which suggests that these changes
reﬂect a more primordial mesenchymal tissue response in
OA. TNC expression is directly related to mechanical load
in ﬁbroblasts49, thus it increased expression in the ruptured
ACL and may represent a response to increased loading
prior to rupture, or an attempt at ligament repair, and
Fig. 2. Hierarchical clustering plot of differentially expressed genes and arrays.
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ACL is consistent with that reported role of this gene in
models of tendon repair50.
Histological changes are reported in other species follow-
ing ACL rupture or transection, such as ligament remo-
delling17 and ligament resorption38, and vary with time
post-injury. Thus the precise cellular composition and activ-
ity within the ruptured ACL are in part a reﬂection of the
length of time post-injury17, and as such the selection of tis-
sues on the basis of time post-injury, or histological grading
of cellular composition could have reduced the heterogene-
ity of the data produced. The insidious onset of ACL rupture
in dogs8 dictates that the precise timing of ACL injury is very
difﬁcult to determine16. Other variables, which were not con-
trolled for the study populations were sex and neuter status.Although the increased risk of ACL rupture for females re-
ported in humans51 is reported in some52 but not in all10
canine epidemiological studies, neuter status is associated
with a risk of ACL rupture, with neutering increasing the risk
of ACL rupture10,52. Clearly the ﬁner nuances may have
been lost for data evaluating ruptured ACLs, and this may
explain in part the limited number of differentially expressed
genes as determined by MA, when compared to RT-qPCR
of a large sample set, and the large variation in fold change
in expression of a number of the genes evaluated.
The highly signiﬁcant increase in expression of ACTA in
the ruptured ACL, as determined by MA, implies that the
cellular differentiation of cells in the epiligamentous synovial
layer to myoﬁbroblasts, as has been reported in the prolifer-
ative phase of the ruptured human ACL17 was occurring in
202 D. N. Clements et al.: Gene expression of canine anterior cruciate ligamentsthe ruptured canine ACL. Furthermore, the signiﬁcant in-
creases in other matrix components suggested a prolifera-
tive response, whilst an epiligamentous inﬂammation
recorded on histological studies of ruptured canine ACL53
is indicated by the increase in COX2 expression.
In summary, we could not identify a transcriptomic basis
to the breed speciﬁc risk for the development of canine ACL
rupture, although a large number of new genes were iden-
tiﬁed as being differentially expressed in ruptured ACL.
The expression proﬁles of ruptured ACLs were similar to
those previously reported for ruptured human ACLs20.Acknowledgements
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